NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
29 hedge funds and large institutions have $379K invested in Navidea Biopharmaceuticals Inc. in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
70% less call options, than puts
Call options by funds: $14K | Put options by funds: $47K
Holders
29
Holding in Top 10
–
Calls
$14K
Puts
$47K
Top Buyers
| 1 | +$18.3K | |
| 2 | +$13.3K | |
| 3 | +$8.4K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.93K |
Top Sellers
| 1 | -$56K | |
| 2 | -$31.3K | |
| 3 | -$12K | |
| 4 |
ACM
Allred Capital Management
Dallas,
Texas
|
-$5.72K |
| 5 |
Citigroup
New York
|
-$66 |